Continuation versus discontinuation of renin–angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial – The Lancet Respiratory Medicine Commentary: Commonly used blood pressure medications safe for COVID-19 patients, study finds – University of Pennsylvania School of Medicine NEW Research—renin–angiotensin system inhibitors can be safely continued in patients admitted […]
The post Randomized trial: Renin–angiotensin system inhibitors can be safely continued in patients admitted to hospital with COVID-19 appeared first on Links Medicus.
Time from Start of Quarantine to SARS-CoV-2 Positive Test Among Quarantined College and University Athletes — 17 States, June–October 2020 – CDC Morbidity and Mortality Weekly Report Commentary on Twitter A new @CDCMMWR looking at college athletes exposed to #COVID19 supports giving health departments options to potentially shorten quarantine periods to increase adherence. Learn […]
The post CDC Study: Among young, healthy athletes exposed to Covid-19, the probability of receiving positive test results after day 10 of quarantine is low (less than 5%) appeared first on Links Medicus.
Implications of Shortened Quarantine Among Household Contacts of Index Patients with Confirmed SARS-CoV-2 Infection — Tennessee and Wisconsin, April–September 2020 – CDC Morbidity and Mortality Weekly Report Commentaries: Shorter Quarantines Can Eliminate Most Contagion. Is Most Enough? New Data – Brief19 AND Some Transmission of SARS-CoV-2 Occurs After Seven, 10 Days – Physician’s Wekly Related […]
The post CDC Study: Reducing quarantine to fewer than 14 days might be easier to comply with but carries some risk of spreading the virus appeared first on Links Medicus.
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults – New England Journal of Medicine Commentaries: Early convalescent plasma may lower risk of severe COVID in seniors – CIDRAP AND Covid-19: Early Plasma Treatment Improved Outcomes in Older Patients – Physician’s Weekly Commentaries on Twitter Just published @NEJM: A small, placebo-controlled randomized […]
The post Randomized trial: Plasma therapy administered early is beneficial in high-risk elderly patients appeared first on Links Medicus.
Blood plasma treatment has limited effect for sickest COVID-19 patients – Imperial College London See also: Expert reaction to REMAP-CAP recruitment of severely ill COVID-19 patients into convalescent plasma trial being paused after initial analysis suggested it did not improve outcomes – Science Media Centre AND Trial of COVID-19 blood plasma finds no benefit in […]
The post Blood plasma treatment has limited effect for sickest COVID-19 patients appeared first on Links Medicus.
|
|
|||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
COVID-19 rapid guideline: vitamin D – National Institute for Health and Care Excellence News release: NICE, PHE and SACN publish rapid COVID-19 guidance on vitamin D Commentaries: Covid and vitamin D: ‘Not enough evidence’ for treatment – BBC AND Covid-19: Evidence is lacking to support vitamin D’s role in treatment and prevention – The BMJ […]
The post NICE Guideline: Do not use Vitamin D to prevent or treat COVID 19 appeared first on Links Medicus.